hey mommocua - will you be averaging downon Curaleaf like olweeb suggests?
If you bought when you said you did - your cost would be around $7.00, might be a good opportunity. The 5 analystrs who've rated Cura in the last month have a consensus price target of $7.73 and have Cura as a "Strong Buy'.
The most recent analysts (Pablo Zuanic isn't one of them) covering Tilray have a price target of $3.54 - and a consensus 'Hold'. lmao
Me?
No, I'll still in the green with Cura - barely - my average cost is $5.45. If anything - I think I'd take a chance on Medmen - maybe pick up a couple of millionn shares at their current share price - $0.00.
I mean, Simple Simon posted Medmen was 'a quality company' - and he should know, right.
The Tilray investors pay him $30 million for a reason.
Comment by
OldDweebon Mar 07, 2024 1:05pm 
10 Views
Post# 35920858
RE:RE:RE:RE:it is clear
What a great opportunity to average down with CURA. Better to take advantage when it's available. lmao